Oppenheimer lowered the firm’s price target on Monday.com (MNDY) to $200 from $300 and keeps an Outperform rating on the shares. The firm views the company’s Q3 report as mixed. Monday.com’s elongating sales cycles from the upmarket sales transition and macro uncertainty are driving soft bookings, the analyst tells investors in a research note. Oppenheimer sees the company’s “inconsistent execution” as feeding the “AI bear narrative on horizontal software companies.” It now sees risk to Monday.com’s 2027 revenue outlook of $1.8B.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNDY:
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
- Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension
- Monday.com falls -18.1%
- Monday.com Stock (MNDY) Slumps 19% after Earnings as Guidance Overshadows Strong Results
- Video: Health insurers weighed on by shutdown news, Trump post
